The Motley Fool

Why Shares Just Got Better

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Older investors withdrew nearly £3bn from savings accounts in the past 12 months, according to research from Aviva. The over-55s have reduced their average cash savings by 10%, disillusioned with interest rates that don’t keep pace with inflation, and instead have turned to higher-risk investments such as equities and corporate bonds.

Good news

That’s good news for shares that are typically found in equity income funds and which sensibly form the cornerstone of any portfolio: solid, dependable companies such as drugs giant GlaxoSmithKline (LSE: GSK)(NYSE: GSK.US) and consumer goods firm Unilever (LSE: ULVR)(NYSE: UL.US).

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

In the past, investors have tended to shift their investments away from risk assets and into cash as they get older. The worry has been that baby-boomers, whose investments have fuelled the stock exchange, would start to withdraw from equities and create a drag on stock prices.

New normal

But if those investors learn a new habit — to stay invested, but in safer equities — then it boosts the long-term prospects for such shares. With the new Bank of England Governor suggesting interest rates will remain low for another three years, while taking a relaxed attitude to inflation, remaining invested into old age could become the new normal.

Of course, we all know that shares can go down as well as up. Older investors require less volatility, so a good spread of relatively safe shares is essential.


That means shares such as GSK. Pharmaceuticals is a classic defensive — i.e. less volatile — sector. Big pharma companies have wrestled with the loss of patents on older blockbuster drugs but GSK is now coming out the other side, with its massive R&D spend creating a strong pipeline of new drugs. Turnover is expected to start climbing again this year.

What’s more, GSK has diversified into less risky vaccines and over-the-counter medicines, and made a big push into emerging markets. It’s currently embroiled in a corruption scandal in China, but that hasn’t hurt the share price.

Unilever is also in a defensive sector, and its strong global brands and scale give it immense market power. It’s the third-largest consumer goods firm in the world, but the best established in emerging markets. A heritage in the former British and Dutch colonies gave it an early foothold. They now account for nearly 60% of sales and are powering growth.

Unilever’s shares are down 12% from their recent all-time high, and it could be a good time to stock up.


GSK and Unilever yield 4.6% and 3.6% respectively. That’s far better than a savings account, even before any prospects for capital growth.

If you are looking for other shares that are suitable for long-term investment, I suggest you read ‘Five Shares to Retire on’. It’s an exclusive report from the Motley Fool that describes other cornerstone shares, including one yielding well over 5%. That’s a great antidote to high inflation and low interest rates. You can download the report by clicking here — it’s free.

> Tony owns shares in GSK, Unilever and Aviva. The Motley Fool has recommended shares in GSK and Unilever.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.